King's College London - David Goldberg Centre

London

1 studies enrolling now · 2 studies all time

What they study most

Parkinson Disease, Parkinson's Disease

Studies at this site

• Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD — Running, not enrolling
• Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study — Available (expanded access)